Get notified when CL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsColgate-Palmolive Q3 sales rise 4.6% to $5.37B; net income up 2.2% to $751M
Filed October 30, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 31, 2025 · ~1 min read
Key Changes
-
high
Worldwide net sales grew 4.6% to $5.37B in Q3 2026, driven by volume growth of 1.7% and pricing of 2.0%.
MD&A: Net Sales verify on EDGAR → -
high
Gross margin improved 80 basis points to 60.2%, reversing last year's decline, on cost savings and pricing.
MD&A: Gross Margin verify on EDGAR → -
high
Restructuring charges of $30M in Q3 and $333M year-to-date reflect an expanded Strategic Growth and Productivity Program with cumulative pre-tax charges now estimated at $350–$550M.
MD&A: Restructuring verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.
Partner
Trade CL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Nov 2, 2026 · How we verify